Zhiqiao Xu
Zhejiang Cancer Hospital(CN)Anshan Hospital(CN)
Publications by Year
Research Areas
Esophageal Cancer Research and Treatment, Gastric Cancer Management and Outcomes, Lung Cancer Treatments and Mutations, Lung Cancer Diagnosis and Treatment, Esophageal and GI Pathology
Most-Cited Works
- → Circular RNA hsa_circ_0000654 promotes esophageal squamous cell carcinoma progression by regulating the miR‐149‐5p/IL‐6/STAT3 pathway(2019)72 cited
- → Efficacy and safety of lapatinib and trastuzumab for HER2-positive breast cancer: a systematic review and meta-analysis of randomised controlled trials(2017)64 cited
- → CircRNA_001569 promotes cell proliferation through absorbing miR-145 in gastric cancer(2018)63 cited
- → Overexpression of HOTAIR leads to radioresistance of human cervical cancer via promoting HIF-1α expression(2018)62 cited
- → Combined Treatment with Autologous CIK Cells, Radiotherapy and Chemotherapy in Advanced Cervical Cancer(2018)20 cited
- → Comparison of concurrent chemoradiotherapy with radiotherapy alone for locally advanced esophageal squamous cell cancer in elderly patients: A randomized, multicenter, phase II clinical trial(2022)18 cited
- → Combination radiotherapy and cantharidin inhibits lung cancer growth through altering tumor infiltrating lymphocytes(2017)17 cited
- → Effects of Down-regulation of HDAC6 Expression on Proliferation, Cell Cycling and Migration of Esophageal Squamous Cell Carcinoma Cells and Related Molecular Mechanisms(2013)15 cited
- → Capecitabine or Capecitabine Plus Oxaliplatin Versus Fluorouracil Plus Cisplatin in Definitive Concurrent Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma (CRTCOESC): A Multicenter, Randomized, Open-Label, Phase 3 Trial(2024)14 cited
- → Pyruvate Kinase M2 Knockdown Suppresses Migration, Invasion, and Epithelial‐Mesenchymal Transition of Gastric Carcinoma via Hypoxia‐Inducible Factor Alpha/B‐Cell Lymphoma 6 Pathway(2020)10 cited